Amphastar Pharmaceuticals Inc (AMPH)
41.00
+0.09
(+0.22%)
USD |
NASDAQ |
Apr 24, 16:00
40.98
-0.02
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Operations (TTM): 183.50M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 183.50M |
September 30, 2023 | 174.86M |
June 30, 2023 | 130.91M |
March 31, 2023 | 78.80M |
December 31, 2022 | 89.18M |
September 30, 2022 | 114.40M |
June 30, 2022 | 96.59M |
March 31, 2022 | 125.93M |
December 31, 2021 | 97.99M |
September 30, 2021 | 74.45M |
June 30, 2021 | 80.68M |
March 31, 2021 | 78.61M |
December 31, 2020 | 57.27M |
September 30, 2020 | 46.02M |
June 30, 2020 | 25.22M |
March 31, 2020 | 46.85M |
December 31, 2019 | 41.76M |
September 30, 2019 | 45.63M |
June 30, 2019 | 73.41M |
March 31, 2019 | 26.22M |
December 31, 2018 | 38.19M |
Date | Value |
---|---|
September 30, 2018 | 38.44M |
June 30, 2018 | 25.13M |
March 31, 2018 | 25.17M |
December 31, 2017 | 39.21M |
September 30, 2017 | 43.45M |
June 30, 2017 | 42.28M |
March 31, 2017 | 47.03M |
December 31, 2016 | 38.56M |
September 30, 2016 | 27.84M |
June 30, 2016 | 30.10M |
March 31, 2016 | 23.27M |
December 31, 2015 | 10.68M |
September 30, 2015 | 19.72M |
June 30, 2015 | 29.79M |
March 31, 2015 | 28.22M |
December 31, 2014 | 21.05M |
September 30, 2014 | 17.24M |
June 30, 2014 | 4.32M |
March 31, 2014 | 23.68M |
December 31, 2013 | 31.04M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
25.22M
Minimum
Jun 2020
183.50M
Maximum
Dec 2023
87.48M
Average
78.80M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
Dentsply Sirona Inc | 377.00M |
Pacira BioSciences Inc | 154.65M |
Organon & Co | 799.00M |
NovaBay Pharmaceuticals Inc | -4.131M |